0001615219-22-000143.txt : 20221108
0001615219-22-000143.hdr.sgml : 20221108
20221108174057
ACCESSION NUMBER: 0001615219-22-000143
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221103
FILED AS OF DATE: 20221108
DATE AS OF CHANGE: 20221108
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Rosenblum Mark J
CENTRAL INDEX KEY: 0001329154
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36812
FILM NUMBER: 221370127
MAIL ADDRESS:
STREET 1: 3990 SPRING VALLEY ROAD, APT. 1218
CITY: DALLAS
STATE: TX
ZIP: 75244
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Salarius Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001615219
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 465087339
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2450 HOLCOMBE BLVD
STREET 2: SUITE J-608
CITY: HOUSTON
STATE: TX
ZIP: 77021
BUSINESS PHONE: 346-772-0346
MAIL ADDRESS:
STREET 1: 2450 HOLCOMBE BLVD
STREET 2: SUITE J-608
CITY: HOUSTON
STATE: TX
ZIP: 77021
FORMER COMPANY:
FORMER CONFORMED NAME: Flex Pharma, Inc.
DATE OF NAME CHANGE: 20140730
4/A
1
wf-form4a_166794723949586.xml
FORM 4/A
X0306
4/A
2022-11-03
2022-11-07
0
0001615219
Salarius Pharmaceuticals, Inc.
SLRX
0001329154
Rosenblum Mark J
C/O SALARIUS PHARMACEUTICALS, INC.
2450 HOLCOMBE BLVD., SUITE X
HOUSTON
TX
77021
0
1
0
0
Exec VP Finance, CFO
Common Stock
2022-11-03
5
A
0
E
7314
1.734
A
13245
D
These shares were acquired under the Salarius Pharmaceuticals, Inc. 2015 Employee Stock Purchase Plan, as amended, in transactions that were exempt under both Rule 16b-3(d) and Rule Rule 16b-3(c)
/s/ Mark J. Rosenblum
2022-11-08